BRCA 1 & 2, ATM, CDH1, CHEK2, MRE11A, MSH6, NBN, p53, PALB2, PMS2, PTEN, RAD50, RECQL, and RINT1 genes
Posted on: Jun 28, 2018 02:22PM
Advanced-Stage, Triple-Negative Breast Cancer in Women With BRCA1/2 Mutation Seems to Respond Better to Carboplatin Than Taxotere
June 26, 2018
Women diagnosed with advanced-stage, triple-negative breast cancer who have a BRCA1 or BRCA2 mutation have a better response to carboplatin than Taxotere. Read more...